Controlled release of simvastatin from biomimetic β-TCP drug delivery system.
Simvastatin have been shown to induce bone formation and there is currently a urgent need to develop an appropriate delivery system to sustain the release of the drug to increase therapeutic efficacy whilst reducing side effects. In this study, a novel drug delivery system for simvastatin by means o...
Guardado en:
Autores principales: | Joshua Chou, Tomoko Ito, David Bishop, Makoto Otsuka, Besim Ben-Nissan, Bruce Milthorpe |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/61309dab47274cd2bc7bb2cf64a3ef46 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Local delivery of controlled-release simvastatin/PLGA/HAp microspheres enhances bone repair
por: Tai IC, et al.
Publicado: (2013) -
Local delivery of controlled-release simvastatin to improve the biocompatibility of polyethylene terephthalate artificial ligaments for reconstruction of the anterior cruciate ligament
por: Zhang P, et al.
Publicado: (2016) -
Enhancement of Simvastatin ex vivo Permeation from Mucoadhesive Buccal Films Loaded with Dual Drug Release Carriers
por: Ahmed TA, et al.
Publicado: (2020) -
Independent Promoter Recognition by TcpP Precedes Cooperative Promoter Activation by TcpP and ToxR
por: A. L. Calkins, et al.
Publicado: (2021) -
ATP-loaded biomimetic nanoparticles as controlled release system for extracellular drugs in cancer applications
por: Díaz-Saldívar P, et al.
Publicado: (2019)